Medical News

RSS

Yale University researchers study potential new treatment to reverse effects of pulmonary fibrosis

Yale University researchers are studying a potential new treatment that reverses the effects of pulmonary fibrosis, a respiratory disease in which scars develop in the lungs and severely hamper breathing.

23 Sep 2014

Distinct patterns of gene expression identified in several groups of pancreatic CTCs

Analysis of circulating tumor cells (CTCs) in a mouse model of pancreatic cancer identified distinct patterns of gene expression in several groups of CTCs, including significant differences from the primary tumor that may contribute to the ability to generate metastases.

23 Sep 2014

Soledad Senga honored with AHA's Lifestyle Change Award

Brown & Toland Physicians, a leading network of independent doctors, honored Soledad Senga on Friday with the Lifestyle Change Award at the annual American Heart Association San Francisco Heart Walk kick-off at Justin Herman Plaza.

23 Sep 2014

New Medicaid enrollees pleased with coverage, but note they still face obstacles

Focus-group research finds that people who received Medicaid coverage under the health law's expansion are generally happy but find roadblocks to getting care, The Washington Post reports.

23 Sep 2014

UHC participates in three-year project to improve quality of care and reduce overall costs

UHC will be participating in a three-year project, funded by the U.S. Department of Health & Human Services, Center for Medicare & Medicaid Services, that aims to improve the quality of care and the patient experience while reducing the overall cost of care by enhancing communication and coordination between primary care physicians and specialists.

23 Sep 2014

Daktari receives NIH SBIR grant to develop point-of-care sickle cell diagnostic test

Daktari Diagnostics, in collaboration with Harvard University, the Medical University of South Carolina, and the University of Zambia in Lusaka, is thrilled to announce that it has been awarded a Small Business Innovation Research grant by the National Institute of Health for a point-of-care sickle cell diagnostic test.

23 Sep 2014

Clontech Laboratories announces launch of DNA SMART ChIP-Seq Kit

Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the launch of the DNA SMART ChIP-Seq Kit. This kit adapts Clontech's patented SMART technology in an innovative manner for use with low-input samples, including both dsDNA and ssDNA templates, to generate ChIP-seq libraries for NGS.

23 Sep 2014

Despite FDA warning, many gynecologists still using controversial surgical tool

Federal officials warned in April that the tool, called a morcellator, can spread undetected cancer.

23 Sep 2014

Elusys completes phase 3 clinical program of obiltoxaximab in healthy adult volunteers

Elusys Therapeutics, Inc., a biopharmaceutical company developing antibody therapies to treat infectious disease, today announced it has completed three phase 3 healthy adult volunteer safety studies of obiltoxaximab (ETI-204).

23 Sep 2014

Avalon Ventures, GSK jointly launch two new early-stage life science companies

Avalon Ventures today announced the launch of two new companies formed through its collaboration with GlaxoSmithKline to fund and launch up to 10 early-stage life science companies.

23 Sep 2014

Congress approves measure to tighten scrutiny, inspections of hospices

Hospice agencies must subject themselves to government inspections at least once every three years under new legislation approved by Congress, part of a measure that addresses concerns about substandard operators in the booming industry.

23 Sep 2014

Arthur J. Gallagher & Co. announces acquisition of The Benfield Group

Arthur J. Gallagher & Co. today announced the acquisition of the healthcare consulting firm, The Benfield Group. Headquartered in St. Louis, the firm also has offices in Chicago, Washington, D.C. and Atlanta.

23 Sep 2014

UAE calls for strengthening global campaign to eradicate polio

At an event hosted by the UAE Ministry of International Cooperation and Development, speaking on behalf of the Minister MICAD, HE Sheikha Lubna Bint Khaled Al Qasimi, HE Dr. Anwar Gargash, Minister of State for Foreign Affairs and Minister of State for Federal National Council Affairs, called for an intensification of the global campaign to eradicate polio.

23 Sep 2014

'Drive-by doctoring' during surgery can add a surprise to the bill

The New York Times examines the growing -- and lucrative -- practice among doctors to call in colleagues to consult during a surgery or afterward. The need is sometimes questionable, and patients often don't even know the second doctor was involved until the bill arrives.

23 Sep 2014

Propanc, Southridge Partners enter into equity purchase agreement

Propanc Health Group Corporation, an emerging healthcare company that focuses on the development of new and proprietary treatments for cancer patients, is pleased to announce it has executed an equity purchase agreement (the "EPA") with Southridge Partners II, L.P., an institutional investor, in the amount of $5 million, which will create significant growth capital for Propanc, enabling the execution of its business plan, on favorable terms.

23 Sep 2014

Leidos awarded NMLC contract to provide services in support of HIV/AIDS prevention programs

Leidos, a national security, health, and engineering solutions company, was awarded a prime contract by the Naval Medical Logistics Command to provide services in support of the Naval Health Research Center's, Department of Defense, HIV/AIDS Prevention Program (DHAPP).

23 Sep 2014

Bose Corporation introduces DuraPulse™, a new instrument for accelerated durability testing of heart valve replacement devices

Bose Corporation has introduced DuraPulse™, a new instrument for accelerated durability testing of heart valve replacement devices. Featuring proprietary Bose® controls and linear motor technology, the DuraPulse system enables research and development engineers to run tests at frequencies higher than ever before -- exceeding 30 Hz without the loss of waveform fidelity. And with Bose PeakIQ™ control technology, the DuraPulse system also prevents high-pressure spikes during valve closing.

From TA Instruments 23 Sep 2014

Medical News

Yale University researchers study potential new treatment to reverse effects of pulmonary fibrosis

Distinct patterns of gene expression identified in several groups of pancreatic CTCs

Soledad Senga honored with AHA's Lifestyle Change Award

New Medicaid enrollees pleased with coverage, but note they still face obstacles

UHC participates in three-year project to improve quality of care and reduce overall costs

Daktari receives NIH SBIR grant to develop point-of-care sickle cell diagnostic test

Clontech Laboratories announces launch of DNA SMART ChIP-Seq Kit

Despite FDA warning, many gynecologists still using controversial surgical tool

Elusys completes phase 3 clinical program of obiltoxaximab in healthy adult volunteers

Avalon Ventures, GSK jointly launch two new early-stage life science companies

Congress approves measure to tighten scrutiny, inspections of hospices

Arthur J. Gallagher & Co. announces acquisition of The Benfield Group

UAE calls for strengthening global campaign to eradicate polio

'Drive-by doctoring' during surgery can add a surprise to the bill

Propanc, Southridge Partners enter into equity purchase agreement

Leidos awarded NMLC contract to provide services in support of HIV/AIDS prevention programs

Bose Corporation introduces DuraPulse™, a new instrument for accelerated durability testing of heart valve replacement devices

Food allergies in inner-city children: an interview with Dr. Robert Wood

Storage symptoms more severe in men with comorbid diabetes

Neuropathic pain phenotype identified in knee osteoarthritis

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Membrane proteins in focus: Turning high-risk targets into routine workflows

Latest News